{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:03:49Z","timestamp":1793930629118,"version":"4.8.0"},"reference-count":56,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"British Association for Lung Research","award":["BALRSS21-04"],"award-info":[{"award-number":["BALRSS21-04"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2022,9,23]]},"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:p>Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is rare, poorly understood, with heterogeneous characteristics resulting in difficult diagnosis. We aimed to systematically review evidence of soluble markers in peripheral blood or bronchoalveolar lavage fluid (BALF) as biomarkers in SSc-ILD.<\/jats:p><jats:sec><jats:title>Method<\/jats:title><jats:p>Five databases were screened for observational or interventional, peer-reviewed studies in adults published between January 2000 and September 2021 that assessed levels of biomarkers in peripheral blood or BALF of SSc-ILD patients compared with healthy controls. Qualitative assessment was performed using Critical Appraisal Skills Programme (CASP) checklists. Standardised mean difference (SMD) in biomarkers were combined in random-effects meta-analyses where multiple independent studies reported quantitative data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>768 published studies were identified; 38 articles were included in the qualitative synthesis. Thirteen studies were included in the meta-analyses representing three biomarkers: KL6, SP-D and IL-8. Greater IL-8 levels were associated with SSc-ILD in both peripheral blood and BALF, overall SMD 0.88 (95% CI 0.61 to 1.15; I<jats:sup>2<\/jats:sup>=1%). Greater levels of SP-D and KL-6 were both estimated in SSc-ILD peripheral blood compared with healthy controls, at an SMD of 1.78 (95% CI 1.50 to 2.17; I<jats:sup>2<\/jats:sup>=8%) and 1.66 (95% CI 1.17 to 2.14; I<jats:sup>2<\/jats:sup>=76%), respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We provide robust evidence that KL-6, SP-D and IL-8 have the potential to serve as reliable biomarkers in blood\/BALF for supporting the diagnosis of SSc-ILD. However, while several other biomarkers have been proposed, the evidence of their independent value in diagnosis and prognosis is currently lacking and needs further investigation.<\/jats:p><\/jats:sec><jats:sec><jats:title>PROSPERO registration number<\/jats:title><jats:p>CRD42021282452.<\/jats:p><\/jats:sec>","DOI":"10.1136\/thorax-2022-219226","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T17:22:56Z","timestamp":1666200176000},"page":"799-807","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":36,"title":["Mediators of systemic sclerosis-associated interstitial lung disease (SSc-ILD): systematic review and meta-analyses"],"prefix":"10.1136","volume":"78","author":[{"given":"Aislin","family":"Fields","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koray N","family":"Potel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhandel","family":"Cabuhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buena","family":"Aziri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1340-2688","authenticated-orcid":false,"given":"Iain D","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1433-0188","authenticated-orcid":false,"given":"Bettina C","family":"Schock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,10,19]]},"reference":[{"key":"2024051320321820000_78.8.799.1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-019-0980-7"},{"key":"2024051320321820000_78.8.799.2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02135-2019"},{"key":"2024051320321820000_78.8.799.3","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10010163","article-title":"Systemic sclerosis: from pathophysiology to novel therapeutic approaches","volume":"10","author":"Benfaremo","year":"2022","journal-title":"Biomedicines"},{"key":"2024051320321820000_78.8.799.4","doi-asserted-by":"publisher","DOI":"10.2147\/OARRR.S226695"},{"key":"2024051320321820000_78.8.799.5","unstructured":"[NICE] NIfHaCE . Nintedanib for treating progressive fibrosing interstitial lung diseases (TA747), 2021 [Accessed 26 Apr 2022]."},{"key":"2024051320321820000_78.8.799.6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/art.41933","article-title":"Systemic sclerosis-associated interstitial lung disease: how to incorporate two food and drug Administration-approved therapies in clinical practice","volume":"74","author":"Khanna","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2024051320321820000_78.8.799.7","first-page":"121","article-title":"The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia","volume":"19","author":"Kim","year":"2002","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024051320321820000_78.8.799.8","doi-asserted-by":"crossref","first-page":"v62","DOI":"10.1093\/rheumatology\/ken272","article-title":"Histopathology and bronchoalveolar lavage","volume":"47 Suppl 5","author":"Silver","year":"2008","journal-title":"Rheumatology"},{"key":"2024051320321820000_78.8.799.9","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000323"},{"key":"2024051320321820000_78.8.799.10","doi-asserted-by":"publisher","DOI":"10.2174\/1874306400903010123"},{"key":"2024051320321820000_78.8.799.11","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.014019"},{"key":"2024051320321820000_78.8.799.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.03.015"},{"key":"2024051320321820000_78.8.799.13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088150"},{"key":"2024051320321820000_78.8.799.14","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02195-y"},{"key":"2024051320321820000_78.8.799.15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206545"},{"key":"2024051320321820000_78.8.799.16","doi-asserted-by":"publisher","DOI":"10.1177\/23971983211036571"},{"key":"2024051320321820000_78.8.799.17","first-page":"1112","article-title":"Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis","volume":"31","author":"Yanaba","year":"2004","journal-title":"J Rheumatol"},{"key":"2024051320321820000_78.8.799.18","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2020.100140","article-title":"Osteopontin links myeloid activation and disease progression in systemic sclerosis","volume":"1","author":"Gao","year":"2020","journal-title":"Cell Rep Med"},{"key":"2024051320321820000_78.8.799.19","unstructured":"Programme Cas . CASPChecklists, on CASP; 2022 [Accessed 28 Apr 2022]."},{"key":"2024051320321820000_78.8.799.20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res Synth Methods"},{"key":"2024051320321820000_78.8.799.21","doi-asserted-by":"crossref","unstructured":"Borenstein MHL , Higgins J , Rothstein H . Effect Sizes Based on Means, p21-32, Introduction to Meta-Analysis, Wiley & Sons. UK: Ltd, 2009.","DOI":"10.1002\/9780470743386.ch4"},{"key":"2024051320321820000_78.8.799.22","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1177\/0962280219889080","article-title":"Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis","author":"McGrath","year":"2020","journal-title":"STAT Methods Med Res"},{"key":"2024051320321820000_78.8.799.23","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3472"},{"key":"2024051320321820000_78.8.799.24","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00017713"},{"key":"2024051320321820000_78.8.799.25","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4096"},{"key":"2024051320321820000_78.8.799.26","doi-asserted-by":"crossref","first-page":"920-927","DOI":"10.1177\/1076029617736382","article-title":"The plasma levels of ADAMTS-13, von Willebrand factor, VWFpp, and fibrin-related markers in patients with systemic sclerosis having thrombosis","volume":"24","author":"Habe","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"2024051320321820000_78.8.799.27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-90333-0"},{"key":"2024051320321820000_78.8.799.28","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2854-1"},{"key":"2024051320321820000_78.8.799.29","doi-asserted-by":"publisher","DOI":"10.1186\/ar2766"},{"key":"2024051320321820000_78.8.799.30","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2010.73"},{"key":"2024051320321820000_78.8.799.31","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13543","article-title":"Prognostic role of KL-6 in SSc-ILD patients with pleuroparenchymal fibroelastosis","volume":"51","author":"d'Alessandro","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"2024051320321820000_78.8.799.32","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/148.3.637"},{"key":"2024051320321820000_78.8.799.33","first-page":"3073","article-title":"KL-6 regulated the expression of HGF, collagen and myofibroblast differentiation","volume":"17","author":"Xu","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2024051320321820000_78.8.799.34","first-page":"27","article-title":"Surfactant protein D and KL-6 serum levels in systemic sclerosis: correlation with lung and systemic involvement","volume":"28","author":"Bonella","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024051320321820000_78.8.799.35","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080633"},{"key":"2024051320321820000_78.8.799.36","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/art.40815","article-title":"Performance of candidate serum biomarkers for systemic sclerosis-associated interstitial lung disease","volume":"71","author":"Elhai","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2024051320321820000_78.8.799.37","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160339"},{"key":"2024051320321820000_78.8.799.38","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170518"},{"key":"2024051320321820000_78.8.799.39","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-018-3987-3"},{"key":"2024051320321820000_78.8.799.40","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13452"},{"key":"2024051320321820000_78.8.799.41","doi-asserted-by":"publisher","DOI":"10.1159\/000050556"},{"key":"2024051320321820000_78.8.799.42","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4439(98)00079-9"},{"key":"2024051320321820000_78.8.799.43","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.2000.279.5.L950"},{"key":"2024051320321820000_78.8.799.44","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.162.1.9903014"},{"key":"2024051320321820000_78.8.799.45","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.00002915"},{"key":"2024051320321820000_78.8.799.46","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.150.5.7952565"},{"key":"2024051320321820000_78.8.799.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2008.10.009"},{"key":"2024051320321820000_78.8.799.48","unstructured":"Wareing N , Li N , Volkmann E . Serum Neutrophil Count Predicts Progression of Interstitial Lung Disease and Mortality in Patients with Systemic Sclerosis Related Interstitial Lung Disease [abstract]. Arthritis Rheumatol 2020;72 https:\/\/acrabstracts.org\/abstract\/serum-neutrophil-count-predicts-progression-of-interstitial-lung-disease-and-mortality-in-patients-with-systemic-sclerosis-related-interstitial-lung-disease\/"},{"key":"2024051320321820000_78.8.799.49","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-1948"},{"key":"2024051320321820000_78.8.799.50","first-page":"274","article-title":"Serum cytokines and their predictive value in pulmonary involvement of systemic sclerosis","volume":"36","author":"Becker","year":"2019","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024051320321820000_78.8.799.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.03.037"},{"key":"2024051320321820000_78.8.799.52","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00018"},{"key":"2024051320321820000_78.8.799.53","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00420.2002"},{"key":"2024051320321820000_78.8.799.54","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00.15121700"},{"key":"2024051320321820000_78.8.799.55","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1986.60.2.532"},{"key":"2024051320321820000_78.8.799.56","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa1024"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2022-219226","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T03:48:20Z","timestamp":1715658500000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2022-219226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,19]]},"references-count":56,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,7,13]]},"published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.1136\/thorax-2022-219226"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2022-219226","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,19]]}}}